Aurobindo Pharma (BOM:524804) Construction In Progress: ₹30,088 Mil (As of Mar. 2026)


BOM:524804 Aurobindo Pharma Ltd BOM:524804
87 GF Score
Price ₹1,593.90
GF Value ₹1,327.48
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Aurobindo Pharma Construction In Progress?

Aurobindo Pharma BOM:524804 -1.62% 87 Construction In Progress is ₹30,088 Mil as of Mar. 2026. GuruFocus rates BOM:524804 with a GF Score™ of 87/100 and a GF Value™ of ₹1,327.48 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Aurobindo Pharma's quarterly construction in progress declined from Sep. 2025 (₹30,395 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹30,088 Mil).

Aurobindo Pharma's annual construction in progress increased from Mar. 2024 (₹28,662 Mil) to Mar. 2025 (₹34,446 Mil) but then declined from Mar. 2025 (₹34,446 Mil) to Mar. 2026 (₹30,088 Mil).

Aurobindo Pharma Construction In Progress Historical Data

* Premium members only.

The historical data trend for Aurobindo Pharma's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aurobindo Pharma Construction In Progress Chart

Aurobindo Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30,414.80 48,082.20 28,661.80 34,445.50 30,088.30

Aurobindo Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34,445.50 0.00 30,394.50 0.00 30,088.30
BOM:524804
87GF Score
Aurobindo Pharma Ltd BOM:524804
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aurobindo Pharma Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹30,088 Mil mean?
Aurobindo Pharma (BOM:524804) has a Construction In Progress of ₹30,088 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Aurobindo Pharma and its competitors.
Is Aurobindo Pharma's Construction In Progress too high?
Aurobindo Pharma's current Construction In Progress is ₹30,088 Mil. Overall, Aurobindo Pharma has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aurobindo Pharma's Construction In Progress compare to ZTS and UTHR?
Aurobindo Pharma's Construction In Progress of ₹30,088 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Aurobindo Pharma and its competitors. Aurobindo Pharma's current Construction In Progress is ₹30,088 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurobindo Pharma stock overvalued right now?
Based on GuruFocus' analysis, Aurobindo Pharma (BOM:524804) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,327.48, compared to a current price of ₹1,593.90 — trading 20.1% above its estimated fair value. The current Construction In Progress is ₹30,088 Mil. Aurobindo Pharma's overall GF Score™ is 87/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Aurobindo Pharma (BOM:524804), the current Construction In Progress is ₹30,088 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aurobindo Pharma (BOM:524804) Overvalued in 2026?

Based on GuruFocus' analysis, Aurobindo Pharma stock appears to be overvalued. The current stock price of ₹1,593.90 is trading 20.1% above its estimated GF Value™ of ₹1,327.48. GuruFocus considers Aurobindo Pharma to be Modestly Overvalued.

Key valuation signals for BOM:524804:

  • Construction In Progress: ₹30,088 Mil
  • GF Value™: ₹1,327.48 vs. price of ₹1,593.90 (20.1% above fair value)
  • GF Score™: 87/100 with 7 warning signs

No single metric tells the full story. See the BOM:524804 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aurobindo Pharma Business Description

Other Exchanges AUROPHARMA:India
Address Plot No. 1, Survey No. 83/1, Galaxy, Floors 22-24, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad, TG, IND, 500032
Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. It is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Its formulations target key therapeutic areas, including Central Nervous System (CNS), Antibiotics, Anti-diabetics, Cardiovascular, Anti-retroviral, Gastroenterology, Oncology, and Dermatology. The operating and reportable segments of the company are; India, the United States of America, Europe, and the Rest of the World. The company generates a majority of its revenue from its business in the United States of America.
87GF Score

Get the complete analysis for BOM:524804

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,593.90
Price
₹1,327.48
GF Value